Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy
Authors:
- 28 July 2006
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 14 (1) , 57-65
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural FluidsClinical Cancer Research, 2005
- Vector Targeting Makes 5-Fluorouracil Chemotherapy Less Toxic and More Effective in Animal Models of Epithelial NeoplasmsClinical Cancer Research, 2004
- Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 statusThe Journal of Gene Medicine, 2004
- Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide systemThe Journal of Gene Medicine, 2002
- The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer modelGene Therapy, 2002
- In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseGene Therapy, 2001
- Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosineCancer Gene Therapy, 2000
- Resistance to 5-FluorouracilGeneral Pharmacology: The Vascular System, 1998
- Concomitant expression ofE. colicytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosineFEMS Microbiology Letters, 1998
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983